EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Frazier Life Sciences is a healthcare investment firm focusing on companies developing novel therapeutics from company formation to scale.
Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
Aspen Neuroscience Lands $115M Series C
Aspen Neuroscience Secures $115M Series C Funding
Tubulis Raises €308M (USD 361M) in Series C Led by Venrock Healthcare Capital Partners